Conference Summaries

The Body Covers: The 4th International Workshop on HIV Drug Resistance and Treatment Strategies

Conference Summaries

Antiviral Therapy

International Medical Press

official report (pdf)

New Medications

Abstract 4. Anti-HIV activity profile of tenofovir (PMPA) against a panel of nucleoside resistant clinical samples

Abstract 38; Genotypic correlates of reduced in vitro susceptibility to ABT 378 in HIV isolates from patients failing protease containing therapy. Kempf D, Isaacson J, King M et al.
Abstract 39; Genotypic and phenotypic analysis of viral isolates from subjects with detectable viral load on therapy with ABT 378/ritonavir. Molla A, Brun S, Mo H et al.
Abstract 5: DAPD: a novel inhibitor of HIV and HBV replication is active against drug resistant virus. Furman PA, Chin R, Borroto-Esoda K et al. and
Abstract 8: BMS 232632 sensitivity of a panel of HIV1 clinical isolates resistant to one or more approved protease inhibitors; Colonno RJ, Hertogs K, Larder BA et al

Nonnucleosides: Is There an Impact from Low Level Baseline Resistance? Is There Hypersensitivity from Nucleoside Resistance?

Abstract 86: Impact of moderate decreases in baseline NNRTI susceptibility on response to antiretroviral therapy. Harrigan PR, Verbiest W, Larder B et al.
Abstract 87: Nonnucleoside reverse transcriptase inhibitor viral hypersensitivity is common and improves short term virologic response. Haubrich R, Whitcomb J, Keiser P, et al.
Abstract 88: Impact of baseline NNRTI resistance on the efficacy of efavirenz combination therapy in NNRTI therapy naïve patients. Bacheler L, Ploughman L, Hertogs K et al.

Update on Testing -- Phenotyping

Abstract 84: Phenotypic resistance testing significantly improves response to therapy: final analysis of a randomized trial (VIRA 3001); Cohen C, Kessler H, Hunt S et al.

Return to The Body's coverage of
The 4th International Workshop on HIV Drug Resistance and Treatment Strategies.

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.